Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04892823

Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors

This project aims to elucidate the important protective elements of social relationships and identify concrete, modifiable behavioral factors that contribute to biological and phenotypic aging in hematopoietic cell transplantation (HCT) survivors and can be used to develop biologically informed interventions to improve quality of life and prolong the healthspan of individuals with accelerated aging.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Froedtert Hospital and the Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Location status: Recruiting

Location contact

Kelly Rentscher, PhD

CONTACT

[email protected]

414-955-8990

Kelly Rentscher, PhD

PRINCIPAL_INVESTIGATOR

About this study

PRIMARY OBJECTIVES:

I. Examine associations between social support, strain, and isolation and phenotypic aging over the 1-year recovery period.

II. Examine associations between social support, strain, and isolation and biological aging over the 1-year recovery period.

III. Test biological aging as a mediator linking social processes and phenotypic aging.

EXPLORATORY OBJECTIVE:

I. Test sex differences in Aims 1 and 2.

OUTLINE:

Adopting a prospective design, participants will complete comprehensive assessments of social processes at 100 days and 1 year after HCT that combine reports of social support, strain, and isolation with a naturalistic observation tool, the Electronically Activated Recorder (EAR), which captures ambient sound bites to assess social interactions in survivors' daily lives16. At each time point, participants will also provide reports of symptoms to characterize phenotypic aging, including cognitive, physical, and functional complaints, and blood samples to assess biological aging, including cellular senescence, DNA damage, SASP, and cellular stress using genome-wide RNA sequencing. Relevant clinical information that could influence biological aging will also be collected from patients' medical records to consider as covariates.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18 years and older who are competent to give their informed consent.
  • Ability to read, speak, and understand English.
  • Received a hematopoietic cell transplant within the previous 100 days.

Exclusion criteria

  • Less then Aged 18 years and older who are competent to give their informed consent.
  • Cannot read, speak, and understand English.
  • Has not received a hematopoietic cell transplant within the previous 100 days.

Treatment and study plan

Biospecimen Collection

Procedure

Undergo collection of blood sample

Electronic Health Record Review

Other

Review of medical records

Questionnaire Administration

Other

Complete questionnaires

Primary outcomes

  1. The number of participants with gene expression of cellular senescence marker p16.

    Time frame: Day 100 and 1 year post-transplant

    This will be measured by mRNA/gene expression.

Study contacts

Contact information is provided by the study sponsor or research team.

Medical College of Wisconsin Cancer Center Clinical Trials Office

CONTACT

[email protected]

866-680-0505 ext. 8900

Sponsors and collaborators

Lead sponsor

Medical College of Wisconsin

Other

Collaborators

  • National Institute on Aging (NIA)

Registry information

Official study title

Accelerated Biological and Phenotypic Aging in Hematopoietic Cell Transplant Survivors: Social Support as a Protective Factor

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
May 19, 2021
Registry last updated
Jul 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.